Human 11␤-hydroxysteroid dehydrogenase type I (11␤-HSD1) is an ER-localized membrane protein that catalyzes the interconversion of cortisone and cortisol. In adipose tissue, excessive cortisol production through 11␤-HSD1 activity has been implicated in the pathogenesis of type II diabetes and obesity. We report here biophysical, kinetic, mutagenesis, and structural data on two ternary complexes of 11␤-HSD1. The combined results reveal flexible active site interactions relevant to glucocorticoid recognition and demonstrate how four 11␤-HSD1 C termini converge to form an as yet uncharacterized tetramerization motif. A C-terminal Pro-Cys motif is localized at the center of the tetramer and forms reversible enzyme disulfides that alter enzyme activity. Conformational flexibility at the tetramerization interface is coupled to structural changes at the enzyme active site suggesting how the central Pro-Cys motif may regulate enzyme activity. Together, the crystallographic and biophysical data provide a structural framework for understanding 11␤-HSD1 activities and will ultimately facilitate the development of specific inhibitors.
Human 11␤-hydroxysteroid dehydrogenase type I (11␤-HSD1) is an ER-localized membrane protein that catalyzes the interconversion of cortisone and cortisol. In adipose tissue, excessive cortisol production through 11␤-HSD1 activity has been implicated in the pathogenesis of type II diabetes and obesity. We report here biophysical, kinetic, mutagenesis, and structural data on two ternary complexes of 11␤-HSD1. The combined results reveal flexible active site interactions relevant to glucocorticoid recognition and demonstrate how four 11␤-HSD1 C termini converge to form an as yet uncharacterized tetramerization motif. A C-terminal Pro-Cys motif is localized at the center of the tetramer and forms reversible enzyme disulfides that alter enzyme activity. Conformational flexibility at the tetramerization interface is coupled to structural changes at the enzyme active site suggesting how the central Pro-Cys motif may regulate enzyme activity. Together, the crystallographic and biophysical data provide a structural framework for understanding 11␤-HSD1 activities and will ultimately facilitate the development of specific inhibitors.
Obesity is an urgent and growing health problem (1) . Because of excessive caloric intake, improper nutrition, and inadequate physical activity, the Center for Disease Control and Prevention has stated that obesity has risen at an epidemic rate during the past 20 years and appears to be worsening (www.cdc. gov/nccdphp/dnpa/obesity). At present, 1 in 4 Americans is clinically obese and often displays symptoms of a condition called the metabolic syndrome (2) . Some of these symptoms include congestive heart failure, abdominal obesity, atherogenic dyslipidemia, hypertension, glucose intolerance, insulin resistance, and type II diabetes. Recent advances in our understanding of the molecular mechanisms relevant to the metabolic syndrome suggest that tissue-specific increases in cortisol levels through the action of 11␤-hydroxysteroid dehydrogenase activity (11␤-HSD) 1 could contribute to the pathogenesis of this prevalent disease (3) (4) (5) (6) .
In humans, two 11␤-HSD isoforms mediate the interconversion of cortisone (inactive glucocorticoid) and cortisol (active glucocorticoid). 11␤-HSD type 1 (11␤-HSD1) is highly expressed in key metabolic tissues including liver, adipose tissue, and the central nervous system (7) (8) (9) . In these tissues, 11␤-HSD1 uses NADPH to reduce cortisone to the active hormone cortisol that activates glucocorticoid receptors (10) . 11␤-HSD type 2 (11␤-HSD2) is an NAD ϩ -dependent dehydrogenase that is expressed in aldosterone-selective tissues (11) (12) (13) . In these tissues, 11␤-HSD2 oxidizes cortisol to cortisone and prevents illicit activation of the mineralocorticoid receptor.
11␤-HSD1 belongs to the short-chain dehydrogenase/reductase (SDR) family of enzymes, of which over 60 members are found in humans (14 -17) . SDRs are reversible NAD(H)/ NADP(H)-dependent oxidoreductases containing a structurally conserved ␣/␤ nucleotide-binding Rossman fold. Within the core structure, two conserved motifs are shared among all SDR enzymes (18) . A dinucleotide-binding P-loop forms a turn between a ␤-strand and an ␣-helix and directly contacts the ribose sugar and pyrophosphate. A Tyr-X-X-X-Lys motif, often in concert with a conserved Ser that orients substrate, catalyzes proton transfer to and from reduced and oxidized reaction intermediates. A flexible region in SDR enzymes, that often changes conformation upon substrate binding to shield the active site from bulk solvent, mediates enzyme specificity (19 -23) . SDR oligomerization and intracellular localization is often mediated by extensions at the N and C termini.
11␤-HSD1 is a NADPH-dependent enzyme that functions predominantly as a reductase in vivo. In cells, a single Nterminal transmembrane helix and associated linker anchors the C-terminal catalytic domain within the lumen of the endoplasmic reticulum (ER) (24, 25) . A growing body of evidence suggests that in the ER 11␤-HSD1 colocalizes with NADPH-generating hexose-6-phosphate dehydrogenase (H6PDH), an enzyme that has been genetically linked to cortisone reductase deficiency in people (26) . Based on these results, it has been proposed that the 11␤-HSD1 reductase activity predominates in metabolic tissues because of an increased NADPH/NADP ϩ ratio within the ER lumen and/or through direct interactions with H6PDH. On the basis of in vitro assays, it has been suggested that 11␤-HSD1 is dimeric, has cooperative enzyme kinetics, and that a C-terminal, primate-specific cysteine residue (Cys 272 ) forms reversible intersubunit disulfides (27, 51) . In contrast to what is observed in vivo, the reductase activity of 11␤-HSD1 is unstable in cell homogenates despite high levels of NADPH (28) . These re-* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The sults strongly argue that enzyme localization to the ER membrane, and/or post-translational modifications are important for dictating enzyme activity and directionality.
Biochemical, genetic, and clinical data all suggest that selective inhibition of 11␤-HSD1 may offer a therapeutic approach for treating metabolic syndrome and other diseases. In mice, adipose-specific overexpression of 11␤-HSD1 leads to the development of visceral obesity, insulin-resistant diabetes, and hyperlipidemia (29) . In contrast, 11␤-HSD1 knockout mice fed high fat diets have low intracellular glucocorticoid levels and are protected from obesity, diabetes, and dyslipidemia (30 -32) . Further validation of 11␤-HSD1 as a therapeutic target comes from experiments that show mice that are exposed to a selective 11␤-HSD1 inhibitor have enhanced hepatic insulin sensitivity and lower blood glucose levels (33, 34) . 11␤-HSD1 inhibitors may also be efficacious as agents to treat cognitive disorders in the elderly and in type II diabetics. Consistent with results from 11␤-HSD1 knockout mice showing protection from age-induced glucocorticoid-associated hippocampal dysfunction (35) , recent human studies with the nonspecific 11␤-HSD1 inhibitor carbenoxelone show a statistically significant improvement in verbal fluency and verbal memory in elderly men and patients with type II diabetes (36) .
The development of new 11␤-HSD1 inhibitors would clearly benefit from an understanding of the enzyme structural features that mediate substrate and inhibitor binding. Here, we present two high resolution crystal structures of 11␤-HSD1 in complex with co-substrate NADP ϩ and the steroidal detergent molecule CHAPS. When combined with biochemical results, the structural results provide an informed basis for understanding cofactor and glucocorticoid recognition and reveal how four 11␤-HSD1 C termini converge to form a tetramerization motif that has not yet been characterized in others proteins. The tetramerization interface is highly malleable and changes conformation to alter the arrangement of active site residues appropriately positioned to modulate substrate binding and product release. Together, these results define the structural basis for 11␤-HSD1 enzyme activity and will ultimately aid in the design of therapeutics that have the potential to treat human diseases such as type II diabetes and obesity.
MATERIALS AND METHODS
Cloning and Expression-The 11␤-HSD1 gene was amplified from IMAGE clone 5193867 (ATCC clone 7277078), using PCR with the primers 5Ј-AACGAGGAATTCAGACCAGAGATG-3Ј and 5Ј-TTACTT-GTTTATGAATCTGTCCAT-3Ј. The resulting PCR product was Topocloned into a modified pBAD-ThioE vector (Invitrogen). The final construct contains the coding sequence for the catalytic domain of 11␤-HSD1 (residues 24 -292) preceded by a MKHQHQHQHQHQHQQPL affinity tag. A single point mutation, C272S, as well as a C-terminal truncation (residues 264 -292) were constructed from this plasmid using QuikChange mutagenesis (Stratagene). Recombinant 11␤-HSD1 was expressed in Escherichia coli DH10b-Tir cells (Invitrogen) grown overnight at 37°C, in Luria broth (LB) supplemented to 0.05 mg/ml kanamycin and induced with 0.2% arabinose and 0.25 mM corticosterone. 11␤-HSD1 was purified from frozen cell pellets that were thawed and resuspended in lysis buffer (30 mM CHAPS, 50 mM Tris-HCl, pH 7.9, 0.15 M NaCl, 0.5 l/ml benzonase, 1 l/ml ReadyLyse), incubated for 30 min at room temperature, and then clarified by centrifugation. The resulting supernatant was loaded on Probond resin (Invitrogen), previously equilibrated with wash buffer (4 mM CHAPS, 50 mM TrisHCl, pH 7.9, 0.25 M NaCl, 40 mM imidazole), and then washed with 10 column volumes of wash buffer. 11␤-HSD1 was eluted with 3 column volumes of wash buffer supplemented to 0.2 M imidazole. The eluate was extensively dialyzed against 4 mM CHAPS, 25 mM Tris-HCl, pH 7.9, 0.25 M NaCl, concentrated to 10 mg/ml, and flash-frozen in 50-l aliquots for long term storage.
Crystallization and Structure Solution-Two crystal forms of C272S 11␤-HSD1 were identified using Nanovolume Crystallization TM methods (37) and reproduced in larger volumes with a reservoir containing 20% polyethylene glycol 3350 and 100 mM MES buffer, pH 6.2. A single site lutetium derivative was obtained by soaking these crystals for 72 h in reservoir solution containing 1 mM lutetium acetate. Crystals were harvested in reservoir solutions supplemented with 20% ethylene glycol, and flash frozen by direct immersion in liquid nitrogen. For the two native crystals, x-ray diffraction data extending to 1.55 and 1.80 Å resolution were collected at the Advanced Light Source (ALS) Beam Line 5.0.3 using a wavelength of 1.00 Å. Both crystal forms of 11␤-HSD1 belong to the monoclinic space group P2 1 and have four monomers in the asymmetric unit. For the lutetium-derivatized crystal, 4 data sets extending to 2.20 Å resolution were collected at ALS Beam Line 5.0.2 using wavelengths of 1.2782, 1.3404, 1.3408, and 1.3412 Å. All data were integrated and scaled using HKL2000 (38) . The position of the lutetium atom in the crystallographic asymmetric unit was determined by SHELXD (39) , and MAD phases were calculated with SHARP (40) . The initial lutetium-bound structure was built manually using the program Xfit (41) and refined without non-crystallographic symmetry restraints in REFMAC (42) . Phases for the two high resolution native structures were obtained by molecular replacement using the program MOLREP, and then improved with Arp/Warp (43) as implemented in CCP4 version 4.0. Iterative cycles of manual model building with Xfit and refinement in REFMAC gave the final refined models. In one of the ternary complexes, electron density consistent with two non-active site steroid molecules was found at the interface between two enzyme dimers. Because of presumed mobility, we could not unambiguously determine the identity of the steroid and thus modeled them as the steroid nucleus of CHAPS. Data collection and refinement statistics are listed in Table I .
Enzyme Kinetics-The dehydrogenase activity of 11␤-HSD1 was measured by incubating 50 nM enzyme with varying amounts of NADP ϩ (0.2-200 M) and cortisol (0.2-200 M) for 60 min in buffer consisting of 50 mM TRIS pH7.5, 150 mM NaCl, 0.5 mM EDTA, and 0.01% Brij35. NADPH production was monitored by measuring fluorescence emission at 460 nm (excitation at 340 nm) using a Molecular Devices SpectraMax Gemini XS fluorescent plate reader. Calibration curves showed a linear increase in fluorescence intensity with increasing NADPH concentration up to 100 M under these conditions. A disulfide-linked form of wild-type 11␤-HSD1 was generated by incubating enzyme (300 M) with 1 mM K 3 Fe(CN) 6 for 2 h at room temperature followed by dialysis to remove excess oxidizing agent.
RESULTS

Biophysical and Kinetic Characterization of Recombinant 11␤-
HSD1-To determine the oligomeric solution structure of our recombinantly expressed truncated forms of wild-type (residues 24 -292) and C272S 11␤-HSD1 enzymes we used static light scattering (SLS) at an enzyme concentration of ϳ100 M. The SLS data gave mondisperse molecular masses of 139,106 Da and 136,615 Da for the wild-type and C272S enzymes, respectively. As the theoretical molecular mass of an 11␤-HSD1 subunit is ϳ32,000 Da, these results support tetrameric assembly of enzyme subunits to form the functional enzyme. Since SDR enzymes often form tetramers through complementary interactions of residues C-terminal to the catalytic core, we also determined the molecular mass of a C-terminally truncated enzyme missing the last 28 residues (residues 24 -264). The SLS data for this truncated enzyme gave an apparent molecular mass of 63,588 Da. This result is consistent with the truncated enzyme forming dimers in solution and verifies that the enzyme C terminus mediates tetramer assembly. We further explored the possibility of forming enzyme disulfides by oxidizing the wild-type enzyme with K 3 Fe(CN) 6 . Using mass spectrometry we verified that this procedure generates a mixture of 31,807 Da monomers and 63,615 Da disulfide-linked dimers (Fig. 1a) . This disulfide-linked form of the enzyme was rapidly eliminated by the addition of 1 mM dithiothreitol (Fig. 1a) . K 3 Fe(CN) 6 addition to the C272S enzyme did not catalyze disulfide bond formation (not shown) indicating Cys 272 mediates intermolecular disulfide formation in the wild-type enzyme.
The dehydrogenase activity of the Cys 272 disulfide-linked, the Cys 272 sulfhydryl, and the C-terminally truncated forms of 11␤-HSD1 was determined using a fluorescence assay that measures the rate of formation of NADPH. Upon oxidation, the enzyme showed a 2-fold increase in k cat that was coupled to a 4-fold increase in K m for substrate, resulting in a net 2-fold decrease in catalytic efficiency (k cat /K m ) for cortisol oxidation (Fig. 1b) . The C-terminally truncated enzyme showed almost identical activity to the Cys 272 sulfhydryl form of the enzyme (data not shown). These results, when combined with our mass spectrometry data, reveal that while the enzyme C terminus is not crucial for catalysis, intermolecular Cys 272 disulfide bond formation must significantly alter its structure to affect the substrate-binding and catalytic properties of the enzyme.
Subunit Structures and Topology of 11␤-HSD1-Two crystal forms of 11␤-HSD1 grown using identical crystallization reagents were identified while screening heavy atom derivatives. Both crystal forms, constructed from what we herein term "interface-open" and "interface-closed" conformations of the enzyme, belong to similar P2 1 space groups although the b-axis is ϳ7-Å longer in the interface-open crystals (Table I) . We used the MAD phases derived from the lutetium-derivatized enzyme to solve the structure of both crystal forms. The interface-open structure was solved to a resolution of 1.55 Å and the interfaceclosed structure was solved to a resolution of 1.80 Å. The overall Rossman fold topology of 11␤-HSD1 resembles other SDR enzymes in which a central 6-stranded, all-parallel ␤-sheet is sandwiched on both sides by 3 ␣-helices (Fig. 2a) . A conformationally variable ␤6-␣6 insertion that forms one wall of the steroid binding pocket, an additional ␤-strand (␤7) and two C-terminal ␣-helices (␣E and ␣F) are appended to the core structure and complete the 11␤-HSD1 fold. Aside from large differences in their quaternary structures, (see below) the eight 11␤-HSD1 subunits in the two crystal forms, including bound cofactor and detergent are similar, with 0.21 Å 2 root mean square (RMS) deviations for all aligned C␣ atoms. In the structures, each active site shows well defined electron density for the cofactor NADP ϩ and the steroidal detergent CHAPS (Fig. 2b) .
Cofactor Binding-NADP ϩ binding to 11␤-HSD1 is similar to other SDR enzymes, with the molecule binding in an extended conformation in which both ribose sugars adopt a C2-endo conformation (Fig. 2c) . Because of the exceptionally high quality of the experimental electron density in both ternary complexes (Fig. 2, b and c) , we could accurately measure the C2N-C3N-C7N-O7N torsion angle. This torsion angle, which defines the planarity of the cofactor carboxamide relative to its attached pyridine ring is indicative of the redox state of the cofactor (22) . In each 11␤-HSD1 subunit, this angle is very close to 180 o , indicating that oxidized NADP ϩ , rather than NADPH is present in the crystal.
The adenine and nicotinamide rings are both well ordered and bind roughly perpendicular to the plane of the ribose sugars with the adenine adopting an anti configuration and the nicotinamide adopting a syn configuration. The adenosine moiety lies in a cleft formed by 4 loops (␤1/␣1, ␤2/␣2, ␤3/␣3, and ␤4/␣4) and an ␣-helix (␣4 (Figs. 1b and 2a) . Consistent with recent biochemical and structural results on 3␤,17␤-hydroxysteroid dehydrogenase (18) , the Asn 143 backbone carbonyl ligates a conserved water that functions as part of a proton relay system with bulk solvent. The oxidized nicotinamide ring is maintained in a syn orientation relative to the ribose by three hydrogen bonds between the carboxamide side chain with the backbone atoms of Ile 218 and an oxygen atom of the NADP ϩ pyrophosphate (Fig. 2c) . Steroid Binding Pocket-In both 11␤-HSD1 ternary complexes the steroidal core of the bound detergent is well ordered and in identical conformations in each of the 8 independent copies of the two different crystallographic asymmetric units. The steroid A ring is positioned at the catalytic end of the substrate binding cleft and the zwitterionic tail of the detergent extends toward solvent through a channel formed by residues of the flexible substrate-binding region and the C terminus of two adjacent subunits (Fig. 2, a and d) .
The three ␣-directed steroidal hydroxyl groups of CHAPS all form bifurcated hydrogen bonds with protein and cofactor atoms in the ternary complexes. The 12-hydroxyl interacts with an active-site water molecule and the oxygen atom of the NADP ϩ carboxamide. The cis-trans AB ring conformation orients the A-ring C-3 hydroxyl to deeply penetrate the catalytic cleft where it interacts with two NADP ϩ pyrophosphate oxygens. The C-6 hydroxyl hydrogen bonds to an active site water molecule and the oxygen atom of Tyr 183 from the catalytic Tyr-X-X-X-Lys motif. With the exception of these hydrophilic contacts, the rest of the steroid-binding pocket is exclusively hydrophobic. assumes different conformations. In one subunit of the interface-closed structure it adopts a helix-loop-helix motif and in a second subunit it forms a helix extended-strand conformation (Fig. 2a) . In two of the interface-closed subunits several residues of this region were disordered and not included in the final model. In the interface-open structure, one subunit forms a helix-loop-helix motif while the other three adopt the helixextended strand conformation. 11␤-HSD1 Subunit Assembly-11␤-HSD1 forms tetramers in solution and in the crystal lattice of both ternary complexes. The tetramer is constructed from two dimers, which are assembled through hydrophobic interactions between residues located on ␣4 and ␣5 (Figs. 2a and 3a) , as seen for other SDR enzymes (20 -22) . To form tetramers, two dimers associate through complementary interactions between pairs of enzyme C termini that are oriented in an antiparallel direction. Each C terminus in the 11␤-HSD1 tetramer runs roughly perpendicular to the dimer 2-fold axis. This arrangement of termini generates a ϳ30-Å long 4-helix bundle-like structure that localizes adjacent enzyme active sites to the top and bottom of the structure (Fig. 3a) . In the assembled tetramer, the N terminus of each subunit is close to the N terminus of the subunit from an adjacent dimer (Fig. 3a) . The two dimers of the tetramer are not symmetrically related: A twisting-like motion about the center of the tetramer rotates one dimer by ϳ30 o relative to the other. In both ternary complexes the C-terminal enzyme tetramerization motif adopts similar helix-strand-helix conformations (Figs. 2a and 3, a and b) . The first helix (␣E) is comprised of residues Ser 261 to Arg 269 , is largely hydrophobic, and is termi- (Fig. 3c) . Ser 195 , which is located adjacent to a possible protein kinase C phosphorylation site (44) , is centrally located in this cluster of charged residues that are unchanged in both structures. Hydrophobic residues on the other face of ␣F are directed toward the interior of the tetramerization interface where they mediate intradimer contacts in the interface-open structure and both intra-and interdimer contacts in the interface-closed structures. In two of the four interfaceclosed 11␤-HSD1 subunits, a short ϳ10 residue C-terminal tail extends from Tyr 280 at the end of ␣F to the conformationally flexible ␤6-␣6 insert of an adjacent subunit in the same dimer (Figs. 2a, 3a , and 5b). Direct interactions between C-terminal tail residue Arg 288 with the backbone carbonyl of steroid contacting residues Ala-226 in one subunit and Ala-228 in another anchor the C-terminal tail to the conformational-variable ␤6-␣6 insert. In the other two subunits of the interface-closed structure, and in all 4 subunits of the interface-open structure, the C-terminal tail is disordered.
Despite the highly similar helix-strand-helix conformations of the enzyme C terminus, the 11␤-HSD1 tetramer interface is remarkably different in the open and closed ternary complexes. In the closed structure, solvent molecules fill a ϳ8 Å ϫ 10 Å ϫ 12 Å central chamber located at the middle of the interface (Fig. 3b) . In the open structure, two bound steroid molecules occupy a similar position (Fig. 3, a and b) . The presence of these steroids forces the two dimers apart, each moving as rigid bodies by ϳ3 Å from their positions in the interface-closed ϩ . In the complex, CHAPS (green) is well ordered and bound with its A-ring deeply penetrating the enzyme active site. Hydrophobic residues (silver) from multiple enzyme loops and helix ␣C make ␣-face, ␤-face, and edge-on interactions with the steroidal core of the bound detergent molecule.
conformation (Figs. 3, a and b, and 5 ). This steroid-induced rigid body movement disrupts most of the interdimer contacts observed in the closed structure and opens the ends of the interface to expose a mostly hydrophobic channel that measures ϳ13 Å ϫ 13 Å ϫ 30 Å. The interface-bound steroid molecules are oriented perpendicular to the channel axis and pack with hydrophobic side chains that line the channel walls (Fig. 3, a and b) .
Transition between the interface-open and interface-closed conformations occurs with striking structural rearrangements ϩ (yellow) and CHAPS (green) bind at two enzyme active sites located at the top and bottom of the enzyme tetramer. Each enzyme subunit is colored differently except for the enzyme N and C termini, which are colored yellow and red, respectively. The conformationally variable ␣6-␤6 inserts are colored blue. The 3 electron difference density (blue) at the center of the interface-open tetramer shows the location of the bound steroid molecules. In both structures, all four N and C termini are localized to the cleft between adjacent dimers. In one dimer pair of the interface-closed structure, the C-terminal tail (red) extends into the active site of the adjacent subunit. b, conformation and residues of the interface-closed and interface-open tetramers. In both structures, four enzyme C termini (red) converge to form a 4 helix-bundle like structure that mediates tetramer formation. The tetramer is formed by complementary hydrophobic interactions at both ends of the interface in the closed structure and through steroid-mediated interactions in the open structure. Pro 271 and Ser 272 (gold) are localized to the center of the enzyme tetramer, which in the closed structure is occupied by solvent molecules (red) and in the open structure is occupied by bound steroid. Trp 263 and Tyr 280 , which change conformation in transitioning between the two structures, are colored purple. The green arrows indicate the paths substrate and product must traverse to access the active site. In the interface-closed structure, movement of Trp 263 and Tyr-open an enzyme conduit (green arrow) that allow interface-bound steroids to access the active site. c, network of salt bridge interactions links side chains on C-terminal helix ␣F to core residues from the same subunit. Ser 195 , a possible protein kinase C phosphorylation site, participates in this in this network of interactions.
at both ends of the tetramer interface (Figs. 3b and 5b) . In the interface-closed structure, C-terminal residues from each enzyme subunit converge at both ends of the tetramer to form two highly complementary interfaces that are separated by the solvent-filled central chamber. These two interfaces mediate all of the dimer-dimer contacts observed in the structure and include two Trp 263 residues from different dimers that are wedged together by packing interactions with Leu 262 , Leu 266 , and Leu 267 from the same C-terminal helix and Ile 275 , Leu 276 , Leu 279 , and Tyr 280 from the two oppositely oriented C termini (Figs. 3b and 5b) . At both ends of the tetramer, the juxtaposition of these hydrophobic residues forms a continuous groove that leads to the enzyme active site and positions Tyr 280 within the active site of an adjacent dimer subunit (Figs. 3b and 5b) . In the open structure, residues at the interface do not form complementary interactions and the two dimers can almost be considered independent since the tetramer is held together solely through interactions mediated by the centrally-bound steroids. The four Trp 263 residues in the interface-open complexes are fully exposed to solvent and, as evidenced by their diffuse electron density, are highly mobile. Furthermore, Tyr 280 backbone and side chain shifts of up to 13 Å repositions its aromatic side chain more deeply within the enzyme active site where it now packs against the ␤-face of CHAPS (Figs. 3b  and 5b ). This repositioning of Tyr 280 changes the direction of the backbone atoms C-terminal to it and reveals an enzyme conduit that links the active site with the center of the tetramer interface. The steroids bound at the center of the interface could access the active site through this enzyme conduit. tween the enzyme and its reaction product cortisol (Fig. 4) . Since 11␤-HSD1 catalyzes interconversion of C-ring 11-keto/ hydroxy groups, we reasoned that the cortisol C11 hydroxyl would closely contact catalytic residues Ser 170 and Tyr 183 . Using this chemical constraint we manually positioned cortisol in the active site and then energy-minimized the system using the MMFF force field (45) with some parts of the active site constrained. The resulting structure-based model predicts that 11␤-HSD1 natural substrate binds in an opposite and nearly perpendicular orientation to that of the steroid ring system of CHAPS. Unlike CHAPS in which a cis-trans A/B ring fusion orients the A ring hydroxyl toward the NADP ϩ nicotinamide, our model suggests that the cortisol D ring converges with the enzyme active site such that its C17 substituents interact with the NADP ϩ pyrophosphate. The A ring is directed toward the distal end of the binding pocket where its C-3 keto group points to solvent. The perpendicular binding orientation of cortisol relative to CHAPS alters the nature and identity of residues contacting its ␣ and ␤ substituents. with the ␣-face, while Leu 206 makes an edge-on interaction. Previous studies on SDR enzymes all support a common reaction mechanism in which an active site Tyr functions as a catalytic acid to protonate the reactive keto oxygen of the bound substrate. In these models for substrate interconversion an active site Ser is often found to stabilize the orientation of bound substrate. A conserved Lys forms hydrogen bonds with the nicotinamide ribose and lowers the pK a of the Tyr-OH to promote proton transfer. The arrangement of these catalytic residues in the 11␤-HSD1 active site is consistent with a similar mechanism for cortisone reduction. Thus, in our structurebased model for steroid reduction the 11-keto position of bound cortisone is anchored in the enzyme active site through interactions with Ser 170 and Tyr 183 . The pK a of this tyrosine is reduced through electrostatic interactions with buried Lys-187. Together, these two residues increase the electrophilicity of the reactive C-11 atom facilitating proton transfer from Tyr 183 to the substrate 11-keto oxygen. Concomitant hydride transfer from NADPH produces the reaction product cortisol and hydrogen exchange with bulk solvent through the conserved relay system (18) reprotonates Tyr 183 . Quaternary Structure, C-terminal 11␤-HSD1 Disulfides, and Enzyme Regulation-The C-terminal structural motif that mediates the quaternary association of 11␤-HSD1 subunits described here has yet to be observed in other protein structures. Although the structure resembles a 4-helix bundle motif, the close localization of the four centrally located helix-disrupting Pro 271 residues makes such a structure unattainable in 11␤-HSD1 and likely imparts extra flexibility in the tetramer that is important for enzyme activity. The close localization of the 11␤-HSD1 C termini also positions the four Ser 272 side chains within close proximity to one another at the center of the tetramer. Within the 11␤-HSD1 dimer the distance between the two Ser 272 O␥ atoms is ϳ7.6 Å. In the interface-closed tetramer the same O␥-O␥ distance is reduced to ϳ6.4 Å for two Ser on similarly oriented helices, and to ϳ7.4 Å for the Ser-Ser pair of oppositely oriented helices (Fig. 5a ). In the interfaceopen structure these distances are increased significantly (Fig.  5a ). The positioning of these Ser 272 residues is significant since our combined biophysical and kinetic data on the wild-type enzyme show that while the C terminus is not necessary for catalysis, the Cys 272 intermolecular disulfides do in fact modulate enzyme activity (Fig. 1) .
Three possible Cys 272 -Cys 272 disulfide pairs (an intradimer disulfide or one of two interdimer disulfides) are consistent with our biochemical data yet the structures indicate significant rearrangements of the enzyme C terminus would be needed to reduce the observed separation of S␥ atoms (Fig. 5a ) to be within the predicted ϳ2.0 Å S-S bond distance observed in other proteins. While our structural data does not allow us to distinguish the exact nature of the Cys 272 disulfide-linked enzyme, three structural features of our C272S tetramer provide insight into how disulfide bond formation might be facilitated. First, Cys 272 would be positioned close to the positively charged helix dipole located at the N terminus of ␣F (Figs. 3b and 5a ). This positioning would increase the disulfide-forming propensity of Cys 272 by lowering the pK A of the reactive sulfhydryl. Second, Cys 272 resides within the solvent-filled central chamber of the interface-closed tetramer (Fig. 3b) . This chamber is large enough to accommodate disulfide exchange catalysts such as glutathione, suggesting these agents, which are abundant in the ER lumen, could assist disulfide bond formation in cells. Third, Cys 272 directly follows Pro 271 . As recent data show a significant increase in the rate of proline isomerization upon disulfide bond formation in cyclic peptides, (46) , and since proline isomerases are frequently localized to the ER lumen (47) isomerization of the protein backbone at Pro 271 , might help facilitate the conformational changes needed to form the Cterminal 11␤-HSD1 disulfides characterized here.
In cells, localization of the 11␤-HSD1 catalytic domain within the oxidizing environment of the ER lumen would further facilitate formation of the 11␤-HSD1 disulfides. Our structures suggest that formation of interdimer disulfides would stabilize the enzyme tetramer by covalently linking two enzyme dimers. The effect of forming intradimer disulfides, however, is difficult to predict. Intradimer linking might increase the hydrophobicity at the center of interface enhancing tetramer formation. Conversely, intradimer disulfides could induce a conformational change in the enzyme C terminus that is incompatible with tetramer formation and would thus favor discreet 11␤-HSD1 dimers. Regardless of the exact nature of are represented as purple and yellow hexagons, respectively. In our dimer model for membrane association, the enzyme is anchored to the bilayer by its N-terminal transmembrane helices as well as through hydrophobic residues on the enzyme C terminus. b, schematic illustrating interactions with two closely spaced membranes within the ER lumen. The highly invaginated membrane structure of this cellular compartment suggest such interactions may be relevant in cells.
the disulfide linkages in cells, cellular stresses that change the redox potential of the ER might change the nature of these disulfides, allowing the enzyme to adopt discreet conformations depending on the exact cellular environment. In this regard it is notable that oxidative damage associated with diabetes mellitus shifts the ER redox environment to a more reducing state (48) , suggesting that the oxidation state of the 11␤-HSD1 disulfides may be altered as the disease progresses.
Implications for Enzyme Activity in Cells-At both ends of the 11␤-HSD1 tetramer, the zwitterionic tail of the bound CHAPS extends out the active site and sits close to the ends of the tetramer interface (Figs. 3a and 5b) . Notably, the CHAPS tail is chemically very similar to the head group of phosphatidylcholine, and suggests that the interactions observed here might mimic the binding of membrane-bound phospholipids within the lumen of the ER. Integrating this information with our structural data for the interface-open and interface-closed conformations, we suggest a specific structural basis for enzyme localization within the ER membrane. Docking our two 11␤-HSD1 ternary complexes onto the luminal surface of the ER membrane suggests two possible models for membrane association of the 11␤-HSD1 tetramer in which four enzyme C termini run roughly perpendicular to the membrane surface (Fig. 6) . In the first model all four N-terminal transmembrane helices are localized in the same lipid bilayer (Fig. 6a) and one end of the tetramerization channel is localized close to the membrane surface and the other is open to the lumen of the ER. In the second model (Fig. 6b) , two transmembrane helices penetrate separate bilayers in the highly invaginated ER lumen and both ends of the C-terminal tetramerization channel are localized to the membrane surface. Notably, the flexible N-terminal linker region not present in our structures should allow for significant flexibility of the catalytic core relative to the N-terminal transmembrane supporting both modes of membrane attachment. The flexible N terminus would further support a model of membrane attachment in which discreet dimers interact with the lipid bilayer through interactions with the two hydrophobic 11␤-HSD1 C termini (Fig. 6) . In all our models of membrane attachment Trp 263 (Figs. 3b and 5b) is immediately adjacent to the lipid bilayer, consistent with the known preference of tryptophan for residing in the interfacial region of zwitterionic phospholipids membrane (49, 50) . A notable feature of the tetramer models is the close proximity of the ends of the 11␤-HSD1 tetramer to the ER membrane. This close localization could allow membrane-localized substrates to directly diffuse into the hydrophobic channel observed in the open structure (Fig. 3, a and b) and then to one of the four connected active sites.
In animals, it is noteworthy that Cys 272 is found only in higher primates. In many other species this Cys is replaced with glycine or serine. When considered in the structural context presented here, this genetic change argues that primates may have evolved an additional regulatory mechanism to control 11␤-HSD1 activity through formation of enzyme disulfides. It will be interesting to determine if this primate-specific change was introduced to enable the enzyme to directly sense the redox potential of the ER and then modulate its activity through conformational change. Regardless of the precise molecular mechanisms that regulate enzyme activity in cells, the close localization of four Pro-Cys motifs at the center of the enzyme tetramer, the structurally defined C-terminal and ␣6-␤6 conformational changes, the location of the protein kinase phosphorylation site, and the C-terminal tail interactions that physically connect neighboring monomers, all support the dynamic assembly of enzyme subunits in the cellular functions of 11␤-HSD1.
